Name: Q&A with Verici Dx CEO, Sara Barrington & Chief Medical Officer, Dr Michael Donovan
Uploaded: 2023-03-23T08:23:06.446467+00:00
Duration: 1984 s
Channel: Vox Markets
Description: Following yesterday’s positive operating update from Verici Dx, CEO Sara Barrington & Chief Medical Officer Dr. Michael Donovan take Vox through the Commercial launch of #VRCI’s 1st kidney transplant test, key USPs & clinical benefits of Tutivia, update on Clarava and future newsflow

Vox Markets

Following yesterday’s positive operating update from Verici Dx, CEO Sara Barrington & Chief Medical Officer Dr. Michael Donovan take Vox through the Commercial launch of #VRCI’s 1st kidney transplant test, key USPs & clinical benefits of Tutivia, update on Clarava and future newsflow

<p>Following yesterday’s positive operating update from Verici Dx, CEO Sara Barrington &amp; Chief Medical Officer Dr. Michael Donovan take Vox through the Commercial launch of #VRCI’s 1st kidney transplant test, key USPs &amp; clinical benefits of Tutivia, update on Clarava and future newsflow</p>

Commercial launch of #VRCI’s 1st kidney transplant test

CMO role

Key USPs & clinical benefits of Tutivia

Improved accuracy of test.

Initial doctor feedback

Significance of CLIA certificate for testing laboratory

Update on Clarava

Synergies from offering a suite of kidney transplant tests

Size of the addressable market

Cash runway & possible strategic options

Future newsflow

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/005/783/005783/video_UmgBpaH.mp4